Mitsubishi UFJ Asset Management UK Ltd. Has $3.08 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mitsubishi UFJ Asset Management UK Ltd. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 268.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,900 shares of the medical equipment provider’s stock after purchasing an additional 4,300 shares during the quarter. Intuitive Surgical accounts for 1.4% of Mitsubishi UFJ Asset Management UK Ltd.’s portfolio, making the stock its 18th largest position. Mitsubishi UFJ Asset Management UK Ltd.’s holdings in Intuitive Surgical were worth $3,080,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the stock. LVW Advisors LLC lifted its position in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares in the last quarter. Hazlett Burt & Watson Inc. lifted its position in Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares in the last quarter. Mitchell Mcleod Pugh & Williams Inc. lifted its position in Intuitive Surgical by 4.1% during the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after buying an additional 20 shares in the last quarter. Fragasso Financial Advisors Inc lifted its position in Intuitive Surgical by 3.0% during the 4th quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock worth $359,000 after buying an additional 20 shares in the last quarter. Finally, Ullmann Wealth Partners Group LLC lifted its position in Intuitive Surgical by 1.6% during the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after buying an additional 21 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jamie Samath sold 269 shares of the business’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the transaction, the insider now owns 8,757 shares in the company, valued at approximately $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,509 shares of company stock valued at $22,602,212 over the last quarter. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $604.12 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $362.14 and a 52-week high of $606.27. The firm has a 50 day moving average price of $541.80 and a two-hundred day moving average price of $500.76. The stock has a market cap of $215.18 billion, a P/E ratio of 97.13, a price-to-earnings-growth ratio of 5.04 and a beta of 1.39.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several recent analyst reports. Robert W. Baird boosted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Mizuho upped their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.